Research programme: allergy gene vaccines - Tunitas TherapeuticsAlternative Names: EPL
Latest Information Update: 16 Dec 2013
At a glance
- Originator Tunitas Therapeutics
- Class Gene therapies; Recombinant proteins
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Hypersensitivity
Most Recent Events
- 16 Dec 2013 Early research in Hypersensitivity in USA (Parenteral)